Legal & General Gbl Health &Pharmaceutical Idx Tst (I) Inc NAV

IMA Sector:

Specialist

ISIN:

GB00B0CNH270

Fund Type:

OEIC

89.88p
   
  • PEP:
  • ISA:
  • CAT Std:
  • Date: 20-Aug-2025
  • Change: 0.97p
  • Change %: 1.09%
  • Currency: GBP
  • YTD change: -7.06p
  • YTD %: -7.28%

Holdings Breakdown

Holding Chart
Key % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Other 76.2%

Top 10 Holdings

Name % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Novartis 4.9%
Pfizer 3.9%
AstraZeneca PLC 3.4%
Wyeth 3.3%
Merck & Co., Inc 3.2%
Sanofi-Aventis 3.1%

Asset Allocation

No asset data available.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Info

Date 20-Aug-2025
NAV 89.88p
Currency GBP
Change 0.97p
% 1.09%
YTD change -7.06p
YTD % -7.28%

Fund Facts

Fund Inception 01/11/2000
Fund Manager Ali Toutounchi
TER 0.31 (31-Dec-2013)

Fund Reports

Minimum Investment
Initial n/a
Additional n/a
Savings n/a
Charges
Initial n/a
Annual Mang't 0.30%
Exit n/a

Risks

Name %
Standard deviation 0.01
Sharpe ratio -0.09

Top of Page